B-cell anomalies in systemic lupus erythematosus;Anomalies lymphocytaires B du lupus érythémateux disséminé

Annales de Medecine Interne

Volumn 153, Issue 8, 2002, Pages 503-512

  Tron, François ^a   Jacquot, Serge ^a   Gilbert, Danièle ^a  

^a HÔPITAL CHARLES NICOLLE   (France)

Author keywords

B lymphocytes; Genetics; Mouse models; Systemic lupus erythematosus

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; CYCLINE; CYTOKINE; DNA; DNA DIRECTED RNA POLYMERASE III; FAS ANTIGEN; FAS LIGAND; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); RIBONUCLEOPROTEIN; RNA;

ANIMAL MODEL; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CONFERENCE PAPER; DISEASE PREDISPOSITION; GENOME; LUPUS ERYTHEMATOSUS; MOUSE; NONHUMAN; PATHOGENESIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, ANTINUCLEAR; B-LYMPHOCYTES; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNITY, CELLULAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MODELS, ANIMAL; RECEPTORS, ANTIGEN, B-CELL; T-LYMPHOCYTES;

EID: 0036971337     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (45)

1. MOHAN C, DATTA SK: Lupus: key pathogenic mechanisms and contributing factors. Clin Immunol Immunopathol, 1995; 77: 209-20.
2. TRON F, GILBERT D: Lupus érythémateux disséminé. In: BACH JF, ed. Traité d'Immunologie. Paris: Médecine-Sciences Flammarion, 1992: 859 et suivantes.
3. MOHAN C, ADAMS S, STANIK V, DATTA SK: Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med, 1993; 177: 1367-81.
4. CASCIOLA-ROSEN LA, ANHALT G, ROSEN A: Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med, 1994; 179: 1317-30.
5. BRENDEL V, DOHLMAN J, BLAISDELL BE, KARLIN S: Very long charge runs in systemic lupus erythematosus associated autoantigens. Proc Natl Acad Sci USA, 1991; 88: 1536-40.
6. THEOFILOPOULOS AN, DIXON FJ: Murine models of systemic lupus erythematosus. Adv Immunol, 1985; 37: 269-390.
7. PENG SL, MADAIO MP, HUGHES DPM, CRISPE IN, OWEN MJ, WEN L, et al.: Murine lupus in the absence of αβ T cells. J Immunol, 1996; 156: 4041-9.
8. CHAN O, SHLOMCHIK MJ: A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice. J Immunol, 1998; 160: 51-9.
9. CHAN OT, HANNUM LG, HABERMAN AM, MADAIO MP, SHLOMCHIK MJ: A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med, 1999; 189: 1639-48.
10. BUDMAN DR, MERCHANT EB, STEINBERG AD, DOFT B, GERSHWIN ME, LIZZIO E, et al.: Increased spontaneous activity of antibody-forming cells in the peripheral blood of patients with active SLE. Arthritis Rheum, 1977; 20: 829-33.
11. MOUTSOPOULOS HM, BOEHM-TRUITT M, KASSAN SS, CHUSED TM: Demonstration of activation of B lymphocytes in New Zealand Black mice at birth by an immunoradiometric assay for murine IgM. J Immunol, 1977; 119: 1639-44.
12. THEOFILOPOULOS AN, SHAWLER DL, EISENBERG RA, DIXON FJ: Splenic immunoglobulin-secreting cells and their regulation in autoimmune mice. J Exp Med, 1980; 151: 446-66.
13. COHEN PL, ZIFF M: Abnormal polyclonal B cell activation in NZB/NZW F1 mice. J Immunol, 1977; 119: 1534-7.
14. MERINO R, IWAMOTO M, FOSSATI L, IZUI S: Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW) F1 and MRL/MpJ-lpr/lpr mice. J Immunol, 1993; 151: 6509-16.
15. IZUI S, KOBAYAKAWA T, ZRYD MJ, LOUIS J, LAMBERT PH: Mechanisms for induction of anti-DNA antibodies by bacterial lipopolysaccharides in mice. II-Correlation between anti-DNA induction and polyclonal antibody formation by various polyclonal activators. J Immunol, 1977; 119: 2157-62.
16. HANG LM, SLACK JH, AMUNDSON C, IZUI S, THEOFILOPOULOS AN, DIXON FJ: Induction of murine autoimmune disease by chronic polyclonal B cell activation. J Exp Med, 1983; 157: 874-83.
17. KLINMAN DM, STEINBERG AD: Systemic autoimmune disease arises from polyclonal B cell activation. J Exp Med, 1987; 165: 1755-60.
18. RADIC MZ, WEIGERT M: Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu Rev Immunol, 1994; 12: 487-520.
19. SHLOMCHIK M, MASCELLI M, SHAN H, RADIC MZ, PISETSKY D, MARSHAK-ROTHSTEIN A, et al.: Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J Exp Med, 1990; 171: 265-92.
20. SHLOMCHIK MJ, AUCOIN AH, PISETSKY D, WEIGERT MG: The structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse. Proc Natl Acad Sci USA, 1987; 84: 9150-4.
21. RADIC MZ, MASCELLI MA, ERIKSON J, SHAN HUA, WEIGERT M: Ig H and L chain contributions to autoimmune specificities. J Immunol, 1991; 146: 176-82.
22. REAP EA, PIECYK ML, OLIVER A, SOBEL ES, WALDSCHMIDT T, COHEN PL, et al.: Phenotypic abnormalities of splenic and bone marrow B cells in lpr and gld mice. Clin Exp Immunopathol, 1996; 78: 21-9.
23. BISHOP GA, RAMIREZ LM, WALDSCHMIDT TJ: Differential responses of Ig and class II-mediated signals in splenic B cell subsets from normal and autoimmune mice. Int Immunol, 1994; 6: 1049-59.
24. HERRON LR, COFFMAN RL, BOND MW, KOTZIN BL: Increased autoantibody production by NZB/NZW B cells in response to IL-5. J Immunol, 1988; 141: 842-8.
25. JONGSTRA-BILEN J, VUKUSIC B, BORAS K, WITHER JE: Resting B cells from autoimmune lupus-prone New Zealand Black and (New Zealand Black x New Zealand White) F1 mice are hyper-responsive to T cell-derived stimuli. J Immunol, 1997; 159: 5810-20.
26. FLESCHER E, FOSSUM D, BALLESTER A, MAIZEL A, SHARMA S, TALAL N: Characterization of B cell growth in systemic lupus erythematosus: effects of recombinant 12-Kda B cell growth factor, interleukin-4 and transforming growth factor-β. Eur J Immunol, 1990; 20: 2425-30.
27. HARIGAI M, HARA M, FUKASAWA C, NAKAZAWA S, KAWAGUCHI Y, KAMATANI N, et al.: Responsiveness of peripheral blood B cells to recombinant CD40 ligand in patients with systemic lupus erythematosus. Lupus, 1999; 8: 227-33.
28. NAGAFUCHI H, SUZUKI N, MIZUSHIMA Y, SAKANE T: Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus. J Immunol, 1993; 151: 6525-34.
29. DESAI-MEHTA A, LIANGJUN L, RAMSEY-GOLDMAN R, DATTA SK: Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest, 1996; 97: 2063-73.
30. BLOSSOM S, CHU EB, WEIGLE WO, GILBERT KM: CD40 ligand expressed on B cells in the BXSB mouse model of systemic lupus erythematosus. J Immunol, 1997; 159: 4580-6.
31. GARCIA-COZAR FJ, MOLINA IJ, CUNDRADO MJ, MARABAYASHI M, PENA J, SANTAMARIA M: Defective B7 expression on antigen-presenting cells underlying T cell activation abnormalities in systemic lupus erythematosus (SLE) patients. Clin Exp Immunol, 1996; 104: 72-9.
32. KOVACS B, THOMAS DE, TSOKOS GC: Elevated in vivo expression of the costimulatory molecule B7-BB1 (CD80) on antigen presenting cells from a patient with SLE. Clin Exp Rheumatol, 1996; 14: 695-7.
33. RATHMELL JC, GOODNOW CC: Effects of the lpr mutation on elimination and inactivation of self-reactive B cells. J Immunol, 1994; 153: 2831-42.
34. CYSTER JG, HARTLEY SB, GOODNOW CC: Competition for follicular niches excludes self-reactive B cells from the recirculating B cell repertoire. Nature, 1994; 371: 389-95.
35. WEINTRAUB JP, EISENBERG RA, COHEN PL: Up-regulation of Fas and the costimulatory molecules B7-1 and B7-2 on peripheral lymphocytes in autoimmune B6/gld mice. J Immunol, 1997; 159: 4117-26.
36. REININGER L, RADASZKIEWICZ T, KOSCO M, MELCHERS F, ROLINK AG: Development of autoimmune disease in SCID mice populated with long-term "in vitro" proliferating (NZB × NZW) F1 pre-B cells. J Exp Med, 1992; 176: 1343-53.
37. PERKINS DL, GLASER RM, MAHON CA, MICHAELSON J, MARSHAK-ROTHSTEIN A: Evidence for an intrinsic B cell defect in lpr/lpr mice apparent in neonatal chimeras. J Immunol, 1990; 145: 549-55.
38. TSUI HW, SIMINOVITCH KA, DE SOUZA L, TSUI FW: Motheaten and viable motheaten mice have a mutation in the haematopoietic cell phosphatase gene. Nat Genet, 1993; 4: 124-9.
39. SCHULTZ LD, SCHWEITZER PA, RAJAN TV, YI T, IHLE JN, MATTHEWS RJ, et al.: Mutations at the murine motheaten locus are within the hematopoietic cell protein tyrosine phosphatase (Hcph) gene. Cell, 1993; 73: 1445-54.
40. HIBBS ML, TARLINTON DM, ARMES J, GRAIL D, HODGSON G, MAGLITTO R, et al.: Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell, 1995; 83: 301-11.
41. O'KEEFE TL, WILLIAMS GT, BATISTA FD, NEUBERGER MS: Deficiency in CD22, a B cell-specific inhibitory receptor is sufficient to predispose to developement of high affinity autoantibodies. J Exp Med, 1999; 189: 1307-13.
42. LIOSSIS SNC, KOVACS B, DENNIS G, KAMMER GM, TSOKOS GC: B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events. J Clin Invest, 1996; 98: 2549-57.
43. KOTZIN BL: Susceptibility loci for lupus: a guiding light from murine models? J Clin Invest, 1997; 99: 557-8.
44. MOHAN C, MOREL L, YANG P, WAKELAND EK Genetic dissection of systemic lupus erythematosus pathogenesis: sle-2 on murine chromosome 4 leads to B cell hyperactivity. J Immunol, 1997; 159: 454-65.
45. TSAO BP, CANTOR RM, KALUNIAN KC, CHEN SL, SHEN N, SONG YW, et al.: Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus (SLE). J Clin Invest, 1997; 99: 725-31.